The companies say they are planning to submit a written notice to the regulatory agency, requesting a re-evaluation of Evenity for the given indication. The new drug works in a different way to ...

EVENITY sales reached nearly $1.6 billion ... strong performance and promising growth opportunities in new indications. CFO Peter Griffith reported total revenues of $33.4 billion for 2024 ...

The final decision for England Wales follows a draft recommendation on Evenity published last November ... was narrower than Evenity's approved indication. The draft guidance prompted a swift ...

Repatha, which treats cholesterol and heart disease, and EVENITY, which targets osteoporosis ... Launches in new indications for UPLIZNA, which treats neuromyelitis optica spectrum disorder ...